GARDP – Global Antibiotic Research & Development Partnership
  • AMR
  • Our work
  • Investing in GARDP
  • News and resources
  • About GARDP
  • Take action
  • AMR
    • AMR
    • Global threat
    • Priority pathogens
      • Neisseria gonorrhoeae
      • Pseudomonas aeruginosa
      • Klebsiella pneumoniae
      • Acinetobacter baumannii
    • Challenges
      • Cancer
      • Conflict
      • Pandemic preparedness
      • Health security
  • Our work
    • Treatments
    • Portfolio
    • Zoliflodacin
    • NeoSep Combinations
    • Cefiderocol
    • BWC0977
    • Debio1453
    • Programmes
    • Serious bacterial infections
      • Projects
      • Press releases
      • Publications
      • Stories
      • Agreements
    • Neonatal sepsis
      • Projects
      • Press releases
      • Publications
      • Stories
    • Sexually transmitted infections
      • Projects
      • Press releases
      • Publications
      • Stories
      • Agreements
    • Discovery and exploratory research
      • Press releases
      • Publications
    • Access to antibiotics
      • Projects
      • Press releases
      • Publications
      • Stories
      • Agreements
    • Scientific affairs and REVIVE
  • Investing in GARDP
    • Investing in GARDP
    • Why GARDP
    • Our impact
    • Funders
  • News and resources
    • News
    • Press releases
    • Opinion
    • Media coverage
    • Events
    • Features
    • Stories
    • Videos
    • Campaign
    • Resources
    • Publications
    • Annual reports
    • GARDP reports
    • Fact sheets
    • Newsletters
  • About GARDP
    • About
    • Who we are
    • Our strategy
    • Global network
    • Partners
    • Agreements
    • Policies
    • People
    • Our governance
    • Team
    • Work with us
  • Take action
    • Take action
    • Donate
    • 2026 campaign
    • Requests for proposals u0026amp; licensing

Antimicrobial resistance, one of the world’s biggest killers, has reached an alarming tipping point.

  • AMR
  • Global threat
  • Priority pathogens
    • Neisseria gonorrhoeae
    • Pseudomonas aeruginosa
    • Klebsiella pneumoniae
    • Acinetobacter baumannii
  • Challenges
    • Cancer
    • Conflict
    • Pandemic preparedness
    • Health security

Changing the way antibiotics are developed and accessed.

  • Treatments
  • Portfolio
  • Zoliflodacin
  • NeoSep Combinations
  • Cefiderocol
  • BWC0977
  • Debio1453
  • Programmes
  • Serious bacterial infections
    • Projects
    • Press releases
    • Publications
    • Stories
    • Agreements
  • Neonatal sepsis
    • Projects
    • Press releases
    • Publications
    • Stories
  • Sexually transmitted infections
    • Projects
    • Press releases
    • Publications
    • Stories
    • Agreements
  • Discovery and exploratory research
    • Press releases
    • Publications
  • Access to antibiotics
    • Projects
    • Press releases
    • Publications
    • Stories
    • Agreements
  • Scientific affairs and REVIVE

A public-health driven model to tackle AMR.

  • Investing in GARDP
  • Why GARDP
  • Our impact
  • Funders

Our latest news and resources.

  • News
  • Press releases
  • Opinion
  • Media coverage
  • Events
  • Features
  • Stories
  • Videos
  • Campaign
  • Resources
  • Publications
  • Annual reports
  • GARDP reports
  • Fact sheets
  • Newsletters

Protecting people from the rise and spread of drug-resistant infections.

  • About
  • Who we are
  • Our strategy
  • Global network
  • Partners
  • Agreements
  • Policies
  • People
  • Our governance
  • Team
  • Work with us

Supporting efforts to ensure the right antibiotics are developed and reach the people who need them.

  • Take action
  • Donate
  • 2026 campaign
  • Requests for proposals & licensing

Financial Report 2022

26 June 2023

Subscribe to our newsletter:

Subscribe

ABOUT GARDP

  • Who we are
  • Global threat
  • Our impact
  • Policies

GLOBAL NETWORK

  • GARDP in Japan
  • GARDP in Latin America
  • GARDP Africa
  • Contact us
  • LinkedIn
  • YouTube
  • X
  • Bluesky

© 2026 GARDP FOUNDATION, all rights reserved.

TERMS OF USE | PRIVACY NOTICE | COOKIES

Sign up for GARDP newsletter

Receive updates on GARDP's efforts to transform lives and counter antibiotic resistance around the world.